Stock Risk Measures for Taro Pharmaceutical Indus

1. Company Info - Description, identity and sector data.
2. Share Data - Stock earnings and key dates.
3. Market Risk - Beta, size, liquidity and momentum measures.
4. Financial Risk - Earnings and dividends.

/ factorpad.com / stocks / f36dcp.html

TARO Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Taro Pharmaceutical Indus. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how TARO stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Pharmaceuticals: Generic industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Identity

• Symbol: TARO
• FactorPad FPID: f36dcp
• SEC CIK: 0000906338
• Share Class FIGI: BBG001SDFY52
• Location: Haifa Bay, Haifa IL
• Web: http://www.taro.com
• Employees: 1,464

Sector and Industry

• Sector: Health Technology
• Industry: Pharmaceuticals: Generic
• SIC Code: 2834

Share Data

Shares and Float

• Shares Outstanding: 38,258,100
• Shares Trading: 8,760,263
• Percent Trading: 22.9 %

Earnings and Dividends

• Trailing 12-month earnings: -6.74
• Next earnings date: 2020-11-10

• Dividends in last 12 months: None
• Ex-dividend date: 2018-12-10

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

• Beta: 0.46 | All: 3 | Sector: 2 | Industry: 34

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

• Market Capitalization: $2,098,456,785 | All: 63 | Sector: 64 | Industry: 100

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

• Daily Dollar Volume: $1,295,720 | All: 100 | Sector: 100 | Industry: 100

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

• Stock Price Change (1-Year): -26.42% | All: 70 | Sector: 87 | Industry: 100

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

• Earnings Yield (E/P): -12.33% | All: 90 | Sector: 86 | Industry: 100

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

• Dividend Yield (D/P): 0% | All: 84 | Sector: 61 | Industry: 84

/ factorpad.com / stocks / f36dcp.html